Key result
The report describes the MYC gene status in a case of angiosarcoma arising at an arteriovenous graft site.
Case Report (n=1)
This case report investigates MYC gene amplification in angiosarcoma associated with an arteriovenous graft, exploring a genetic aberration that may unify clinicopathologic subdivisions of the disease.
Answers are grounded in this paper and cite their sources.
Documents MYC amplification in AVG-associated angiosarcoma; extends genetic spectrum but leaves open diagnostic and prognostic implications.
Angiosarcoma arising in association with an arteriovenous graft (AVG) or fistula is a unique clinicopathologic scenario that appears to be gaining recognition in the literature. Among reported cases, none has described high-level MYC gene amplification, a genetic aberration that is increasingly unifying the various clinicopathologic subdivisions of angiosarcoma. We therefore report the MYC gene status in a case of angiosarcoma arising at an AVG site.
No takes yet. Share an insight, caveat, or question.
Paral et al. (2015) conducted a case report in Angiosarcoma arising at an arteriovenous graft site (n=1). MYC gene status assessment was evaluated on MYC gene amplification status. The report describes the MYC gene status in a case of angiosarcoma arising at an arteriovenous graft site.
Synapse has enriched 10 related papers. Consider them for comparative context: